| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Environmental Pollutants | 34 | 2023 | 180 | 8.040 |
Why?
|
| Fertilization in Vitro | 29 | 2023 | 47 | 6.410 |
Why?
|
| Environmental Exposure | 36 | 2021 | 269 | 5.350 |
Why?
|
| Fluorocarbons | 19 | 2023 | 82 | 3.660 |
Why?
|
| Alkanesulfonic Acids | 18 | 2023 | 54 | 3.180 |
Why?
|
| Phthalic Acids | 9 | 2022 | 28 | 3.130 |
Why?
|
| Air Pollution | 21 | 2021 | 54 | 3.120 |
Why?
|
| Pregnancy | 54 | 2023 | 2334 | 3.000 |
Why?
|
| Arsenic | 13 | 2020 | 46 | 2.970 |
Why?
|
| Air Pollutants | 22 | 2022 | 75 | 2.960 |
Why?
|
| Maternal Exposure | 15 | 2022 | 75 | 2.720 |
Why?
|
| Follicular Fluid | 13 | 2023 | 18 | 2.490 |
Why?
|
| China | 47 | 2023 | 138 | 2.000 |
Why?
|
| Premature Birth | 7 | 2022 | 150 | 1.910 |
Why?
|
| Trace Elements | 8 | 2021 | 23 | 1.900 |
Why?
|
| Fetal Development | 6 | 2022 | 70 | 1.840 |
Why?
|
| Particulate Matter | 22 | 2022 | 41 | 1.800 |
Why?
|
| Oocytes | 10 | 2020 | 57 | 1.780 |
Why?
|
| Polychlorinated Biphenyls | 10 | 2022 | 147 | 1.750 |
Why?
|
| Female | 131 | 2023 | 38074 | 1.710 |
Why?
|
| Phenols | 7 | 2022 | 73 | 1.580 |
Why?
|
| Humans | 160 | 2023 | 68618 | 1.410 |
Why?
|
| Metals | 6 | 2015 | 100 | 1.390 |
Why?
|
| Water Pollutants, Chemical | 7 | 2017 | 328 | 1.380 |
Why?
|
| Infertility | 6 | 2021 | 26 | 1.300 |
Why?
|
| Caprylates | 12 | 2020 | 32 | 1.240 |
Why?
|
| Adult | 73 | 2022 | 21403 | 1.150 |
Why?
|
| Cadmium | 9 | 2020 | 21 | 1.150 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2023 | 154 | 1.120 |
Why?
|
| Anovulation | 2 | 2020 | 6 | 1.120 |
Why?
|
| Thyroxine | 8 | 2016 | 62 | 1.110 |
Why?
|
| Embryo, Mammalian | 6 | 2011 | 176 | 1.080 |
Why?
|
| Occupational Exposure | 7 | 2021 | 122 | 1.000 |
Why?
|
| Endocrine Disruptors | 4 | 2021 | 31 | 1.000 |
Why?
|
| Metals, Heavy | 6 | 2018 | 18 | 0.990 |
Why?
|
| Reproduction | 3 | 2016 | 48 | 0.980 |
Why?
|
| Drinking Water | 5 | 2017 | 33 | 0.960 |
Why?
|
| Pregnancy Outcome | 7 | 2020 | 157 | 0.940 |
Why?
|
| Lipoproteins, HDL | 5 | 2017 | 113 | 0.910 |
Why?
|
| Male | 75 | 2022 | 37321 | 0.900 |
Why?
|
| Abortion, Spontaneous | 3 | 2015 | 17 | 0.890 |
Why?
|
| Heart Defects, Congenital | 7 | 2022 | 596 | 0.890 |
Why?
|
| Fertilization | 3 | 2011 | 10 | 0.850 |
Why?
|
| Birth Weight | 5 | 2023 | 186 | 0.810 |
Why?
|
| Placenta | 1 | 2022 | 101 | 0.800 |
Why?
|
| Estrogens, Non-Steroidal | 2 | 2011 | 5 | 0.790 |
Why?
|
| Cohort Studies | 18 | 2023 | 2358 | 0.780 |
Why?
|
| Obesity | 10 | 2022 | 1076 | 0.770 |
Why?
|
| Case-Control Studies | 16 | 2021 | 1553 | 0.760 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 4 | 2017 | 13 | 0.730 |
Why?
|
| Thyrotropin | 6 | 2016 | 49 | 0.720 |
Why?
|
| Cross-Sectional Studies | 25 | 2022 | 2279 | 0.710 |
Why?
|
| Biomarkers | 14 | 2022 | 1593 | 0.690 |
Why?
|
| New York | 11 | 2019 | 223 | 0.690 |
Why?
|
| Thyroid Hormones | 3 | 2016 | 31 | 0.680 |
Why?
|
| Prospective Studies | 15 | 2023 | 3705 | 0.670 |
Why?
|
| Ovulation Induction | 5 | 2019 | 9 | 0.670 |
Why?
|
| Child | 26 | 2023 | 6405 | 0.660 |
Why?
|
| Food Contamination | 5 | 2020 | 56 | 0.650 |
Why?
|
| Adiposity | 5 | 2022 | 88 | 0.610 |
Why?
|
| Water Supply | 2 | 2015 | 54 | 0.600 |
Why?
|
| DDT | 2 | 2017 | 19 | 0.600 |
Why?
|
| Oocyte Retrieval | 3 | 2014 | 4 | 0.600 |
Why?
|
| Mercury | 8 | 2020 | 34 | 0.590 |
Why?
|
| Risk Assessment | 9 | 2020 | 2007 | 0.580 |
Why?
|
| Hypertension | 7 | 2020 | 1535 | 0.580 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2007 | 13 | 0.560 |
Why?
|
| Hydrocarbons, Chlorinated | 2 | 2008 | 25 | 0.560 |
Why?
|
| Adolescent | 27 | 2022 | 8912 | 0.560 |
Why?
|
| Ovary | 2 | 2016 | 99 | 0.550 |
Why?
|
| Waterborne Diseases | 1 | 2016 | 1 | 0.550 |
Why?
|
| Foodborne Diseases | 1 | 2016 | 14 | 0.550 |
Why?
|
| Parks, Recreational | 3 | 2020 | 11 | 0.540 |
Why?
|
| Risk Factors | 19 | 2022 | 5731 | 0.530 |
Why?
|
| Residence Characteristics | 5 | 2020 | 252 | 0.530 |
Why?
|
| Cyclonic Storms | 1 | 2016 | 59 | 0.530 |
Why?
|
| Testosterone | 2 | 2020 | 96 | 0.520 |
Why?
|
| Drinking | 1 | 2015 | 35 | 0.520 |
Why?
|
| Infant, Newborn | 11 | 2022 | 2455 | 0.510 |
Why?
|
| Internship and Residency | 1 | 2021 | 596 | 0.510 |
Why?
|
| Child, Preschool | 13 | 2022 | 3187 | 0.510 |
Why?
|
| Estrogens | 1 | 2016 | 173 | 0.510 |
Why?
|
| Odds Ratio | 8 | 2022 | 880 | 0.510 |
Why?
|
| Folic Acid | 3 | 2020 | 123 | 0.480 |
Why?
|
| Data Interpretation, Statistical | 2 | 2006 | 329 | 0.480 |
Why?
|
| Nitrogen Dioxide | 11 | 2021 | 13 | 0.480 |
Why?
|
| Young Adult | 21 | 2020 | 5717 | 0.480 |
Why?
|
| Lung | 7 | 2020 | 849 | 0.480 |
Why?
|
| Pilot Projects | 11 | 2021 | 1342 | 0.480 |
Why?
|
| Inhalation Exposure | 3 | 2019 | 33 | 0.470 |
Why?
|
| Cities | 11 | 2020 | 29 | 0.470 |
Why?
|
| Metabolic Syndrome | 3 | 2021 | 191 | 0.470 |
Why?
|
| Romania | 8 | 2018 | 11 | 0.460 |
Why?
|
| Infant, Low Birth Weight | 1 | 2014 | 84 | 0.450 |
Why?
|
| Live Birth | 2 | 2019 | 8 | 0.450 |
Why?
|
| Multivariate Analysis | 6 | 2017 | 1046 | 0.450 |
Why?
|
| Thyroid Gland | 3 | 2014 | 67 | 0.450 |
Why?
|
| Androgens | 2 | 2010 | 41 | 0.440 |
Why?
|
| Pets | 3 | 2022 | 10 | 0.440 |
Why?
|
| Lipids | 3 | 2019 | 298 | 0.430 |
Why?
|
| Asthma | 4 | 2020 | 345 | 0.430 |
Why?
|
| Ovarian Follicle | 6 | 2020 | 21 | 0.420 |
Why?
|
| Overweight | 5 | 2020 | 186 | 0.420 |
Why?
|
| Fishes | 5 | 2019 | 77 | 0.420 |
Why?
|
| Blood Pressure | 5 | 2019 | 1451 | 0.410 |
Why?
|
| Lead | 7 | 2018 | 45 | 0.410 |
Why?
|
| Middle Aged | 32 | 2020 | 21147 | 0.410 |
Why?
|
| Autistic Disorder | 2 | 2010 | 77 | 0.400 |
Why?
|
| Fertility | 2 | 2017 | 60 | 0.400 |
Why?
|
| Gonadotropins | 1 | 2011 | 4 | 0.400 |
Why?
|
| Environmental Monitoring | 9 | 2022 | 180 | 0.390 |
Why?
|
| Estradiol | 1 | 2011 | 176 | 0.360 |
Why?
|
| Finger Phalanges | 1 | 2010 | 2 | 0.360 |
Why?
|
| Plants | 2 | 2021 | 26 | 0.350 |
Why?
|
| Cholesterol, LDL | 1 | 2010 | 161 | 0.350 |
Why?
|
| Respiratory Function Tests | 5 | 2021 | 123 | 0.350 |
Why?
|
| Hand, Foot and Mouth Disease | 2 | 2020 | 2 | 0.350 |
Why?
|
| Fetus | 2 | 2022 | 157 | 0.340 |
Why?
|
| Uric Acid | 2 | 2019 | 37 | 0.340 |
Why?
|
| Water | 1 | 2010 | 230 | 0.330 |
Why?
|
| Dietary Supplements | 3 | 2020 | 332 | 0.330 |
Why?
|
| Schools | 5 | 2021 | 156 | 0.330 |
Why?
|
| Logistic Models | 6 | 2019 | 1420 | 0.330 |
Why?
|
| Pesticide Residues | 1 | 2008 | 4 | 0.330 |
Why?
|
| Sex Factors | 6 | 2019 | 1266 | 0.330 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2020 | 127 | 0.320 |
Why?
|
| Aged | 22 | 2020 | 14862 | 0.320 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2008 | 39 | 0.310 |
Why?
|
| Chlamydia Infections | 1 | 2008 | 41 | 0.310 |
Why?
|
| Benzhydryl Compounds | 4 | 2012 | 62 | 0.300 |
Why?
|
| Cardiovascular Diseases | 3 | 2020 | 940 | 0.300 |
Why?
|
| Embryo Transfer | 4 | 2017 | 18 | 0.290 |
Why?
|
| Neuropsychological Tests | 3 | 2019 | 517 | 0.290 |
Why?
|
| Abortion, Habitual | 1 | 2006 | 13 | 0.280 |
Why?
|
| Epidemiologic Research Design | 1 | 2006 | 5 | 0.280 |
Why?
|
| Halogenated Diphenyl Ethers | 4 | 2022 | 17 | 0.280 |
Why?
|
| Prednisone | 1 | 2006 | 104 | 0.270 |
Why?
|
| Military Personnel | 2 | 2008 | 221 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2020 | 1085 | 0.270 |
Why?
|
| Linear Models | 7 | 2019 | 521 | 0.260 |
Why?
|
| Progesterone | 1 | 2006 | 115 | 0.260 |
Why?
|
| Infant | 7 | 2022 | 2891 | 0.260 |
Why?
|
| Gestational Age | 3 | 2015 | 389 | 0.250 |
Why?
|
| Micronutrients | 2 | 2019 | 31 | 0.250 |
Why?
|
| Skin Neoplasms | 3 | 2014 | 375 | 0.250 |
Why?
|
| Reference Values | 1 | 2006 | 579 | 0.250 |
Why?
|
| Aspirin | 1 | 2006 | 295 | 0.250 |
Why?
|
| Mass Screening | 2 | 2008 | 843 | 0.240 |
Why?
|
| Triiodothyronine | 2 | 2014 | 22 | 0.240 |
Why?
|
| Polymorphism, Genetic | 3 | 2014 | 301 | 0.240 |
Why?
|
| Child Development | 2 | 2019 | 102 | 0.230 |
Why?
|
| Animals | 19 | 2022 | 20881 | 0.230 |
Why?
|
| Sunlight | 2 | 2014 | 59 | 0.230 |
Why?
|
| Fungicides, Industrial | 1 | 2003 | 7 | 0.230 |
Why?
|
| Urban Population | 3 | 2019 | 255 | 0.230 |
Why?
|
| Bayes Theorem | 5 | 2023 | 307 | 0.230 |
Why?
|
| Prevalence | 9 | 2019 | 1619 | 0.220 |
Why?
|
| Spectrophotometry, Atomic | 2 | 2014 | 11 | 0.220 |
Why?
|
| Insecticides | 1 | 2003 | 43 | 0.220 |
Why?
|
| Time Factors | 6 | 2017 | 4655 | 0.220 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 438 | 0.220 |
Why?
|
| Socioeconomic Factors | 6 | 2019 | 955 | 0.220 |
Why?
|
| Depression | 3 | 2019 | 943 | 0.220 |
Why?
|
| Abortion, Threatened | 1 | 2022 | 3 | 0.220 |
Why?
|
| Environmental Health | 2 | 2020 | 23 | 0.220 |
Why?
|
| Exercise | 4 | 2020 | 658 | 0.220 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 2077 | 0.210 |
Why?
|
| Hyperuricemia | 2 | 2019 | 13 | 0.210 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2022 | 57 | 0.210 |
Why?
|
| Influenza, Human | 2 | 2020 | 79 | 0.210 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2022 | 38 | 0.210 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 848 | 0.200 |
Why?
|
| Cleavage Stage, Ovum | 2 | 2012 | 4 | 0.200 |
Why?
|
| Femoracetabular Impingement | 1 | 2022 | 9 | 0.200 |
Why?
|
| Regression Analysis | 4 | 2018 | 737 | 0.200 |
Why?
|
| Seafood | 3 | 2020 | 17 | 0.200 |
Why?
|
| Hypersensitivity | 2 | 2019 | 52 | 0.200 |
Why?
|
| Retrospective Studies | 9 | 2022 | 7277 | 0.190 |
Why?
|
| Sleep | 2 | 2022 | 263 | 0.190 |
Why?
|
| Dibutyl Phthalate | 1 | 2021 | 5 | 0.190 |
Why?
|
| Pesticides | 1 | 2021 | 41 | 0.190 |
Why?
|
| Sleep Wake Disorders | 1 | 2022 | 94 | 0.190 |
Why?
|
| Cosmetics | 1 | 2020 | 5 | 0.180 |
Why?
|
| Enterovirus A, Human | 1 | 2020 | 3 | 0.180 |
Why?
|
| Pediatric Obesity | 1 | 2022 | 92 | 0.180 |
Why?
|
| Food Packaging | 1 | 2020 | 8 | 0.180 |
Why?
|
| Viral Vaccines | 1 | 2020 | 17 | 0.180 |
Why?
|
| Folic Acid Deficiency | 1 | 2020 | 16 | 0.180 |
Why?
|
| Menstrual Cycle | 3 | 2012 | 64 | 0.180 |
Why?
|
| Enterovirus | 1 | 2020 | 12 | 0.180 |
Why?
|
| Body Mass Index | 5 | 2022 | 867 | 0.180 |
Why?
|
| Embryo Implantation | 2 | 2017 | 17 | 0.180 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 102 | 0.180 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2020 | 37 | 0.180 |
Why?
|
| Child Health | 1 | 2020 | 15 | 0.180 |
Why?
|
| Anti-Allergic Agents | 1 | 2020 | 27 | 0.180 |
Why?
|
| Health Impact Assessment | 1 | 2019 | 1 | 0.180 |
Why?
|
| Forced Expiratory Volume | 4 | 2020 | 87 | 0.170 |
Why?
|
| Sulfur Dioxide | 4 | 2021 | 4 | 0.170 |
Why?
|
| Vitamins | 1 | 2020 | 134 | 0.170 |
Why?
|
| Dyslipidemias | 1 | 2020 | 98 | 0.170 |
Why?
|
| Respiratory Tract Diseases | 1 | 2019 | 43 | 0.170 |
Why?
|
| Pregnancy Rate | 1 | 2019 | 14 | 0.170 |
Why?
|
| Nutritional Status | 1 | 2020 | 112 | 0.170 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 81 | 0.170 |
Why?
|
| Semen | 2 | 2021 | 29 | 0.170 |
Why?
|
| Soot | 1 | 2019 | 2 | 0.170 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2019 | 4 | 0.170 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2019 | 106 | 0.170 |
Why?
|
| Construction Materials | 1 | 2019 | 7 | 0.170 |
Why?
|
| Foot-and-Mouth Disease Virus | 1 | 2019 | 1 | 0.170 |
Why?
|
| Blood Glucose | 2 | 2019 | 631 | 0.160 |
Why?
|
| Air Pollution, Indoor | 1 | 2019 | 26 | 0.160 |
Why?
|
| Penis | 1 | 2019 | 25 | 0.160 |
Why?
|
| Oxidative Stress | 3 | 2020 | 718 | 0.160 |
Why?
|
| Soil | 1 | 2018 | 51 | 0.160 |
Why?
|
| Airway Obstruction | 1 | 2019 | 49 | 0.160 |
Why?
|
| Soil Pollutants | 1 | 2018 | 42 | 0.160 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 1173 | 0.160 |
Why?
|
| Environment | 1 | 2019 | 115 | 0.160 |
Why?
|
| Vegetables | 1 | 2018 | 76 | 0.160 |
Why?
|
| Antibodies, Viral | 1 | 2019 | 110 | 0.150 |
Why?
|
| Cough | 1 | 2018 | 65 | 0.150 |
Why?
|
| Otitis Media | 1 | 2018 | 35 | 0.150 |
Why?
|
| Postpartum Period | 2 | 2008 | 67 | 0.150 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2017 | 34 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2020 | 276 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 274 | 0.150 |
Why?
|
| Reproductive Health | 2 | 2021 | 6 | 0.150 |
Why?
|
| Embryonic Development | 2 | 2008 | 100 | 0.150 |
Why?
|
| Breast Feeding | 1 | 2019 | 159 | 0.150 |
Why?
|
| Infertility, Female | 1 | 2017 | 25 | 0.150 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 189 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2020 | 326 | 0.150 |
Why?
|
| Aryldialkylphosphatase | 1 | 2017 | 11 | 0.150 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2021 | 139 | 0.140 |
Why?
|
| Triglycerides | 2 | 2010 | 184 | 0.140 |
Why?
|
| Endometriosis | 1 | 2017 | 56 | 0.140 |
Why?
|
| Ownership | 3 | 2022 | 18 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2019 | 193 | 0.140 |
Why?
|
| South Carolina | 2 | 2021 | 2752 | 0.140 |
Why?
|
| New York City | 1 | 2016 | 49 | 0.140 |
Why?
|
| Rural Population | 1 | 2019 | 398 | 0.140 |
Why?
|
| Carcinoma, Basal Cell | 2 | 2013 | 40 | 0.140 |
Why?
|
| Clinical Competence | 1 | 2021 | 657 | 0.140 |
Why?
|
| Registries | 4 | 2020 | 733 | 0.130 |
Why?
|
| Poisson Distribution | 1 | 2016 | 85 | 0.130 |
Why?
|
| Nutrition Surveys | 1 | 2017 | 208 | 0.130 |
Why?
|
| Cholesterol | 2 | 2010 | 331 | 0.130 |
Why?
|
| Body Size | 1 | 2015 | 39 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 1465 | 0.130 |
Why?
|
| Bias | 2 | 2006 | 148 | 0.130 |
Why?
|
| Respiratory Sounds | 3 | 2020 | 35 | 0.130 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2015 | 15 | 0.130 |
Why?
|
| Epidemiology | 1 | 2015 | 14 | 0.130 |
Why?
|
| Metalloids | 1 | 2015 | 2 | 0.130 |
Why?
|
| Head | 1 | 2015 | 59 | 0.130 |
Why?
|
| Education, Public Health Professional | 1 | 2015 | 7 | 0.130 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 694 | 0.130 |
Why?
|
| Arsenic Poisoning | 1 | 2015 | 5 | 0.130 |
Why?
|
| Arsenicals | 1 | 2015 | 8 | 0.130 |
Why?
|
| Zinc | 2 | 2016 | 73 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2020 | 447 | 0.120 |
Why?
|
| Education, Graduate | 1 | 2015 | 30 | 0.120 |
Why?
|
| Microsatellite Repeats | 1 | 2014 | 40 | 0.120 |
Why?
|
| Ozone | 3 | 2019 | 13 | 0.120 |
Why?
|
| Mirex | 2 | 2005 | 5 | 0.120 |
Why?
|
| Hexachlorobenzene | 2 | 2005 | 7 | 0.120 |
Why?
|
| Great Lakes Region | 2 | 2005 | 10 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 58 | 0.120 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2014 | 46 | 0.120 |
Why?
|
| Lipid Peroxidation | 2 | 2012 | 94 | 0.120 |
Why?
|
| Anemia | 1 | 2015 | 104 | 0.120 |
Why?
|
| Anthropometry | 2 | 2015 | 64 | 0.120 |
Why?
|
| Specimen Handling | 1 | 2014 | 47 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 627 | 0.120 |
Why?
|
| Sports | 2 | 2005 | 55 | 0.110 |
Why?
|
| DNA Repair | 1 | 2014 | 127 | 0.110 |
Why?
|
| Self Report | 1 | 2015 | 371 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 792 | 0.110 |
Why?
|
| Quality Control | 2 | 2010 | 81 | 0.110 |
Why?
|
| Rivers | 1 | 2013 | 43 | 0.110 |
Why?
|
| Public Health | 1 | 2015 | 201 | 0.110 |
Why?
|
| Drug Combinations | 2 | 2020 | 304 | 0.110 |
Why?
|
| Hydrocortisone | 1 | 2014 | 291 | 0.110 |
Why?
|
| Ultraviolet Rays | 1 | 2013 | 130 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 615 | 0.100 |
Why?
|
| Smoking | 2 | 2015 | 1452 | 0.100 |
Why?
|
| Cognition | 1 | 2016 | 513 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 299 | 0.100 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2012 | 52 | 0.100 |
Why?
|
| United States | 5 | 2022 | 7367 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 286 | 0.100 |
Why?
|
| Enzymes | 1 | 2011 | 25 | 0.100 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2011 | 8 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2013 | 629 | 0.100 |
Why?
|
| Seasons | 2 | 2022 | 129 | 0.100 |
Why?
|
| Luteinizing Hormone | 1 | 2010 | 31 | 0.090 |
Why?
|
| Menstruation | 1 | 2010 | 20 | 0.090 |
Why?
|
| Bangladesh | 1 | 2010 | 14 | 0.090 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2010 | 12 | 0.090 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2010 | 29 | 0.090 |
Why?
|
| DNA Fragmentation | 1 | 2010 | 85 | 0.090 |
Why?
|
| Curriculum | 1 | 2015 | 575 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2015 | 1330 | 0.090 |
Why?
|
| India | 1 | 2010 | 41 | 0.090 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 134 | 0.090 |
Why?
|
| Nickel | 1 | 2010 | 18 | 0.090 |
Why?
|
| Shoulder Joint | 1 | 2012 | 110 | 0.090 |
Why?
|
| Thymus Gland | 1 | 2010 | 97 | 0.090 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2010 | 41 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 333 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2012 | 193 | 0.090 |
Why?
|
| Dogs | 2 | 2022 | 490 | 0.090 |
Why?
|
| Selenium | 1 | 2010 | 36 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 237 | 0.090 |
Why?
|
| Metaphase | 1 | 2010 | 12 | 0.090 |
Why?
|
| Longitudinal Studies | 2 | 2015 | 1054 | 0.090 |
Why?
|
| Magnesium | 1 | 2010 | 110 | 0.090 |
Why?
|
| Aging | 1 | 2016 | 911 | 0.090 |
Why?
|
| Particle Size | 2 | 2022 | 201 | 0.090 |
Why?
|
| Psychological Theory | 1 | 2010 | 27 | 0.090 |
Why?
|
| Hormones | 1 | 2009 | 42 | 0.090 |
Why?
|
| Fisheries | 1 | 2009 | 6 | 0.090 |
Why?
|
| Cholesterol, HDL | 1 | 2009 | 112 | 0.090 |
Why?
|
| Vital Capacity | 2 | 2019 | 43 | 0.080 |
Why?
|
| F2-Isoprostanes | 1 | 2009 | 14 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2014 | 7029 | 0.080 |
Why?
|
| Decanoic Acids | 1 | 2009 | 5 | 0.080 |
Why?
|
| Thyroid Function Tests | 1 | 2009 | 21 | 0.080 |
Why?
|
| Receptors, Estrogen | 1 | 2009 | 142 | 0.080 |
Why?
|
| Surveys and Questionnaires | 4 | 2019 | 2800 | 0.080 |
Why?
|
| Radiography | 1 | 2010 | 572 | 0.080 |
Why?
|
| Streptococcus pyogenes | 1 | 2008 | 20 | 0.080 |
Why?
|
| Vaccination | 2 | 2020 | 189 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2014 | 824 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 4848 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 499 | 0.080 |
Why?
|
| Streptococcal Infections | 1 | 2008 | 53 | 0.080 |
Why?
|
| Manganese | 2 | 2018 | 26 | 0.080 |
Why?
|
| Chromium | 2 | 2018 | 26 | 0.080 |
Why?
|
| Epidemiologic Studies | 2 | 2020 | 33 | 0.080 |
Why?
|
| Influenza Vaccines | 1 | 2008 | 56 | 0.070 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2007 | 1 | 0.070 |
Why?
|
| Creatine Kinase | 1 | 2007 | 46 | 0.070 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2007 | 38 | 0.070 |
Why?
|
| Austria | 1 | 2006 | 17 | 0.070 |
Why?
|
| Matched-Pair Analysis | 1 | 2006 | 25 | 0.070 |
Why?
|
| Homeostasis | 2 | 2018 | 291 | 0.070 |
Why?
|
| Calcium | 1 | 2010 | 929 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 1040 | 0.070 |
Why?
|
| Hematinics | 1 | 2006 | 52 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2012 | 381 | 0.060 |
Why?
|
| Risk | 2 | 2019 | 563 | 0.060 |
Why?
|
| Mice | 5 | 2020 | 8474 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1536 | 0.060 |
Why?
|
| Genotype | 1 | 2007 | 786 | 0.060 |
Why?
|
| Semen Analysis | 2 | 2014 | 5 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 234 | 0.060 |
Why?
|
| Attention | 2 | 2016 | 225 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 240 | 0.060 |
Why?
|
| Incidence | 2 | 2019 | 1603 | 0.060 |
Why?
|
| Europe | 2 | 2014 | 196 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 2223 | 0.060 |
Why?
|
| Suppressor Factors, Immunologic | 1 | 2003 | 1 | 0.060 |
Why?
|
| Ambulatory Care Facilities | 1 | 2004 | 91 | 0.060 |
Why?
|
| Sequence Analysis, Protein | 1 | 2003 | 16 | 0.050 |
Why?
|
| Patient Selection | 1 | 2007 | 592 | 0.050 |
Why?
|
| Uncertainty | 1 | 2022 | 31 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 47 | 0.050 |
Why?
|
| Carcinogens | 1 | 2022 | 86 | 0.050 |
Why?
|
| Diet | 2 | 2019 | 514 | 0.050 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2022 | 20 | 0.050 |
Why?
|
| Cats | 1 | 2022 | 292 | 0.050 |
Why?
|
| Pregnant Women | 1 | 2022 | 50 | 0.050 |
Why?
|
| Prognosis | 2 | 2019 | 2093 | 0.050 |
Why?
|
| Hip Joint | 1 | 2022 | 64 | 0.050 |
Why?
|
| Femur | 1 | 2022 | 113 | 0.050 |
Why?
|
| Calibration | 1 | 2021 | 73 | 0.050 |
Why?
|
| Weight Gain | 1 | 2022 | 135 | 0.050 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2021 | 58 | 0.050 |
Why?
|
| Vision Disorders | 1 | 2021 | 94 | 0.050 |
Why?
|
| Beverages | 1 | 2021 | 50 | 0.050 |
Why?
|
| Graft vs Host Disease | 1 | 2003 | 163 | 0.050 |
Why?
|
| Protective Factors | 1 | 2020 | 24 | 0.050 |
Why?
|
| Homocysteine | 1 | 2020 | 28 | 0.040 |
Why?
|
| Dual Oxidases | 1 | 2020 | 1 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 3259 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2020 | 43 | 0.040 |
Why?
|
| Dust | 1 | 2020 | 9 | 0.040 |
Why?
|
| Social Class | 1 | 2020 | 127 | 0.040 |
Why?
|
| Sulfonic Acids | 1 | 2019 | 6 | 0.040 |
Why?
|
| Public Policy | 1 | 2020 | 71 | 0.040 |
Why?
|
| Respiration Disorders | 1 | 2019 | 20 | 0.040 |
Why?
|
| Isomerism | 1 | 2019 | 63 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 182 | 0.040 |
Why?
|
| Morbidity | 1 | 2019 | 130 | 0.040 |
Why?
|
| Temperature | 1 | 2021 | 341 | 0.040 |
Why?
|
| Polyvinyl Chloride | 1 | 2019 | 3 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 532 | 0.040 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2019 | 6 | 0.040 |
Why?
|
| Floors and Floorcoverings | 1 | 2019 | 2 | 0.040 |
Why?
|
| Fasting | 1 | 2019 | 75 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2019 | 127 | 0.040 |
Why?
|
| Echocardiography | 1 | 2022 | 515 | 0.040 |
Why?
|
| Satellite Imagery | 1 | 2018 | 1 | 0.040 |
Why?
|
| Manufacturing and Industrial Facilities | 1 | 2018 | 1 | 0.040 |
Why?
|
| Time | 1 | 2019 | 57 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 597 | 0.040 |
Why?
|
| Spirometry | 1 | 2019 | 47 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2019 | 32 | 0.040 |
Why?
|
| Housing | 1 | 2019 | 38 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2019 | 46 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2019 | 131 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 114 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2020 | 358 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2004 | 659 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 205 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2004 | 703 | 0.040 |
Why?
|
| Transfection | 2 | 2014 | 782 | 0.040 |
Why?
|
| Genitalia, Male | 1 | 2017 | 14 | 0.040 |
Why?
|
| Genitalia, Female | 1 | 2017 | 20 | 0.040 |
Why?
|
| Hospitals, General | 1 | 2017 | 12 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2018 | 117 | 0.040 |
Why?
|
| Time-to-Pregnancy | 1 | 2017 | 1 | 0.040 |
Why?
|
| Educational Status | 1 | 2018 | 273 | 0.040 |
Why?
|
| Molybdenum | 1 | 2016 | 7 | 0.040 |
Why?
|
| Maternal Age | 1 | 2017 | 70 | 0.040 |
Why?
|
| Cobalt | 1 | 2016 | 37 | 0.040 |
Why?
|
| Poverty | 1 | 2018 | 219 | 0.030 |
Why?
|
| Reaction Time | 1 | 2016 | 170 | 0.030 |
Why?
|
| Glucose | 1 | 2018 | 307 | 0.030 |
Why?
|
| Executive Function | 1 | 2016 | 106 | 0.030 |
Why?
|
| Insulin | 1 | 2018 | 619 | 0.030 |
Why?
|
| Copper | 1 | 2016 | 149 | 0.030 |
Why?
|
| Schools, Public Health | 1 | 2015 | 4 | 0.030 |
Why?
|
| Michigan | 1 | 2015 | 68 | 0.030 |
Why?
|
| Visual Perception | 1 | 2016 | 124 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 807 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2014 | 5 | 0.030 |
Why?
|
| Heredity | 1 | 2014 | 9 | 0.030 |
Why?
|
| Texas | 1 | 2015 | 92 | 0.030 |
Why?
|
| Heavy Metal Poisoning | 1 | 2014 | 1 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2014 | 14 | 0.030 |
Why?
|
| Learning | 1 | 2016 | 186 | 0.030 |
Why?
|
| Poisoning | 1 | 2014 | 21 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2014 | 119 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 93 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2014 | 207 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2014 | 191 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 1030 | 0.030 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2014 | 79 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 284 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 240 | 0.030 |
Why?
|
| Slovakia | 1 | 2013 | 4 | 0.030 |
Why?
|
| Hungary | 1 | 2013 | 10 | 0.030 |
Why?
|
| Shellfish | 1 | 2013 | 8 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2015 | 502 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 1864 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 2791 | 0.030 |
Why?
|
| Isoprostanes | 1 | 2012 | 3 | 0.030 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2012 | 4 | 0.030 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2012 | 17 | 0.030 |
Why?
|
| Linoleic Acids | 1 | 2012 | 12 | 0.030 |
Why?
|
| Body Burden | 1 | 2012 | 27 | 0.030 |
Why?
|
| Cadaver | 1 | 2012 | 136 | 0.030 |
Why?
|
| Cell Shape | 1 | 2011 | 37 | 0.020 |
Why?
|
| Dialysis | 1 | 2011 | 30 | 0.020 |
Why?
|
| Solid Phase Extraction | 1 | 2011 | 4 | 0.020 |
Why?
|
| Limit of Detection | 1 | 2011 | 11 | 0.020 |
Why?
|
| Cell Count | 1 | 2011 | 248 | 0.020 |
Why?
|
| Electrochemical Techniques | 1 | 2011 | 23 | 0.020 |
Why?
|
| DNA Degradation, Necrotic | 1 | 2010 | 1 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 786 | 0.020 |
Why?
|
| Uncoupling Agents | 1 | 2010 | 10 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 2010 | 29 | 0.020 |
Why?
|
| Hydrazones | 1 | 2010 | 11 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2010 | 18 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 58 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2010 | 44 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2010 | 40 | 0.020 |
Why?
|
| Vitamin E | 1 | 2010 | 55 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2010 | 47 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2020 | 2689 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 1056 | 0.020 |
Why?
|
| Alabama | 1 | 2010 | 98 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 756 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2012 | 652 | 0.020 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2010 | 5 | 0.020 |
Why?
|
| Liver X Receptors | 1 | 2010 | 8 | 0.020 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2010 | 18 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 148 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 329 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 489 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 210 | 0.020 |
Why?
|
| DNA | 1 | 2012 | 597 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2010 | 120 | 0.020 |
Why?
|
| Chickens | 1 | 2010 | 232 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2008 | 24 | 0.020 |
Why?
|
| Recreation | 1 | 2008 | 19 | 0.020 |
Why?
|
| Penicillin G Benzathine | 1 | 2008 | 3 | 0.020 |
Why?
|
| Antioxidants | 1 | 2010 | 304 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2008 | 39 | 0.020 |
Why?
|
| Ascorbic Acid | 1 | 2008 | 45 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1753 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2008 | 62 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 659 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2008 | 149 | 0.020 |
Why?
|
| Lactates | 1 | 2007 | 29 | 0.020 |
Why?
|
| Rhabdomyolysis | 1 | 2007 | 16 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2550 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1745 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1196 | 0.020 |
Why?
|
| Exercise Test | 1 | 2007 | 242 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2007 | 221 | 0.020 |
Why?
|
| Mitochondria | 1 | 2010 | 643 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2010 | 1692 | 0.020 |
Why?
|
| Heart Rate | 1 | 2007 | 568 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 396 | 0.010 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2003 | 3 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 320 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 63 | 0.010 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 257 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2004 | 298 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 376 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 498 | 0.010 |
Why?
|
| Anxiety | 1 | 2004 | 422 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 1752 | 0.010 |
Why?
|
| Kidney | 1 | 2003 | 945 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2004 | 1242 | 0.010 |
Why?
|